Asset Dedication’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Asset Dedication's CRL Position: Q3 2026 in Review
Asset Dedication held its Charles River Laboratories (CRL) position steady in Q3 2026 at 3 shares worth $886. The position accounts for ﹤0.01% of the portfolio, ranked #1078.
Asset Dedication first reported a position in CRL in Q3 2021 and has held it in 17 quarters since. The position peaked at $25K in Q1 2024. 515 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Asset Dedication held 3 shares of Charles River Laboratories worth $886 as of Q3 2026.
- Asset Dedication left its Charles River Laboratories share count unchanged in Q3 2026.
- Charles River Laboratories made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1078 holding.
- Asset Dedication first reported a position in Charles River Laboratories in Q3 2021 and has held it in 17 quarters since.
- Asset Dedication's Charles River Laboratories position peaked at $25K in Q1 2024.
- 515 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.